Discovery of Bicycloalkyl Urea Melanin Concentrating Hormone Receptor Antagonists: Orally Efficacious Antiobesity Therapeutics
Journal of Medicinal Chemistry2005Vol. 48(7), pp. 2274–2277
Citations Over TimeTop 10% of 2005 papers
Mark D. McBriar, Henry Guzik, Ruo Xu, Jaroslava Paruchova, Shengjian Li, Anandan Palani, John W. Clader, William J. Greenlee, Brian E. Hawes, Timothy J. Kowalski, Kim O’Neill, Brian D. Spar, Blair Weig
Abstract
Melanin concentrating hormone (MCH) is involved in regulation of food intake and energy homeostasis. Antagonists of the MCH receptor are expected to affect food intake and weight gain, making MCH-R1 an attractive target for obesity treatment. Herein, we report the discovery of a novel, orally active series of MCH-R1 antagonists that exhibit in vivo efficacy in rodent obesity models.
Related Papers
- → RFamide Peptide QRFP43 Causes Obesity with Hyperphagia and Reduced Thermogenesis in Mice(2006)99 cited
- → Effect of Direct Injection of Melanin‐Concentrating Hormone into the Paraventricular Nucleus: Further Evidence for a Stimulatory Role in the Adrenal Axis via SLC‐1(2003)89 cited
- → Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats(2001)68 cited
- → Induction of Prolactin Receptors in Rat Liver after the Administration of Growth Hormone*(1981)49 cited
- → Alterations in the binding characteristics of glucocorticoid receptors from obese zucker rats(1990)18 cited